Institutional Ownership Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC). We have compiled data on the 113 institutions that hold shares in the stock, with a total of 59.3 Million shares, which have been reported (via 13F filing form) to have a value of $419 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nextech Invest Ag
|
May 15, 2024 Q1 2024 |
5,285,714
shares
|
$37.4 Million
13.59% of portfolio
|
Q1 2024
Added 23.33%
|
|
|
Vr Adviser, LLC
New York, NY |
May 15, 2024 Q1 2024 |
4,394,527
shares
|
$31.1 Million
5.19% of portfolio
|
Q1 2024
Added 80.97%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2024 Q1 2024 |
4,142,855
shares
|
$29.3 Million
2.99% of portfolio
|
Q1 2024
Added 93.33%
|
|
|
Viking Global Investors LP
|
May 15, 2024 Q1 2024 |
4,000,000
shares
|
$28.3 Million
0.21% of portfolio
|
Q1 2024
New holding
|
|
|
Alkeon Capital Management LLC
New York, NY |
May 14, 2024 Q1 2024 |
3,704,096
shares
|
$26.2 Million
0.09% of portfolio
|
Q1 2024
Added 2.77%
|
|
|
Column Group LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
3,540,777
shares
|
$25 Million
30.34% of portfolio
|
Q1 2024
Reduced 0.77%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
3,418,068
shares
|
$24.2 Million
1.34% of portfolio
|
Q1 2022
Reduced 1.47%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
3,178,185
shares
|
$22.5 Million
0.0% of portfolio
|
Q1 2024
Added 2.67%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
2,882,055
shares
|
$20.4 Million
0.0% of portfolio
|
Q1 2024
Added 27.95%
|
|
|
Commodore Capital LP
New York, NY |
May 15, 2024 Q1 2024 |
2,000,000
shares
|
$14.1 Million
2.38% of portfolio
|
Q1 2024
New holding
|
|
|
Boxer Capital, LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
1,732,571
shares
|
$12.2 Million
1.24% of portfolio
|
Q2 2023
Added 64.38%
|
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
1,716,081
shares
|
$12.1 Million
0.0% of portfolio
|
Q1 2024
Added 116.38%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,566,736
shares
|
$11.1 Million
0.0% of portfolio
|
Q1 2024
Added 140.46%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2024 Q1 2024 |
1,510,861
shares
|
$10.7 Million
0.26% of portfolio
|
Q1 2024
Reduced 12.86%
|
|
|
Nea Management Company, LLC
Timonium, MD |
May 15, 2024 Q1 2024 |
1,500,000
shares
|
$10.6 Million
1.45% of portfolio
|
Q1 2024
New holding
|
|
|
Silverarc Capital Management, LLC
|
May 14, 2024 Q1 2024 |
1,113,007
shares
|
$7.87 Million
5.14% of portfolio
|
Q1 2024
Reduced 4.87%
|
|
|
First Turn Management, LLC
Del Mar, CA |
May 03, 2024 Q1 2024 |
1,097,571
shares
|
$7.76 Million
2.26% of portfolio
|
Q1 2024
New holding
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2024 Q1 2024 |
1,030,400
shares
|
$7.28 Million
0.03% of portfolio
|
Q1 2024
New holding
|
|
|
Invus Financial Advisors, LLC
New York, NY |
May 15, 2024 Q1 2024 |
1,007,575
shares
|
$7.12 Million
11.01% of portfolio
|
Q4 2020
Reduced -0.0%
|
|
|
Euclidean Capital LLC
New York, NY |
May 15, 2024 Q1 2024 |
989,410
shares
|
$7 Million
1.75% of portfolio
|
Q3 2023
Added 32.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
911,633
shares
|
$6.45 Million
0.0% of portfolio
|
Q1 2024
Added 4.2%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Apr 22, 2024 Q1 2024 |
849,681
shares
|
$6.01 Million
1.56% of portfolio
|
Q4 2023
Added 9.22%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2024 Q1 2024 |
750,516
shares
|
$5.31 Million
0.0% of portfolio
|
Q4 2023
Added 0.01%
|
|
|
Memorial Sloan Kettering Cancer Center
New York, NY |
Nov 14, 2023 Q3 2023 |
602,272
shares
|
$4.26 Million
14.83% of portfolio
|
Q4 2020
New holding
|
|
|
Invesco Ltd.
Atlanta, GA |
May 14, 2024 Q1 2024 |
494,168
shares
|
$3.49 Million
0.0% of portfolio
|
Q1 2024
Added 33.84%
|
|